Exact Sciences Corporatio...

NASDAQ: EXAS · Real-Time Price · USD
45.39
0.40 (0.89%)
At close: Aug 15, 2025, 1:11 PM

Exact Sciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
600.89M 605.38M 242.49M 315.47M
Short-Term Investments
437.14M 172.27M 389.56M 715M
Long-Term Investments
n/a n/a 47.5M 33.4M
Other Long-Term Assets
169.72M 177.39M -425.47M -451.32M
Receivables
248.97M 203.62M 158.04M 216.65M
Inventory
162.38M 127.47M 118.26M 104.99M
Other Current Assets
122.05M 85.63M 73.9M n/a
Total Current Assets
1.57B 1.19B 982.26M 1.43B
Property-Plant & Equipment
810.63M 842.06M 851.76M 754.47M
Goodwill & Intangibles
3.38B 4.26B 4.3B 4.43B
Total Long-Term Assets
4.36B 5.28B 5.24B 5.26B
Total Assets
5.93B 6.47B 6.23B 6.68B
Account Payables
89.57M 78.82M 74.92M 67.83M
Deferred Revenue
n/a n/a 3.1M 398.56M
Short-Term Debt
249.15M 50M n/a n/a
Other Current Liabilities
393.46M 31.99M 21.51M 50.65M
Total Current Liabilities
732.19M 514.7M 412.75M 517.07M
Long-Term Debt
2.32B 2.31B 2.24B 2.18B
Other Long-Term Liabilities
472.64M 335.98M 352.46M 417.78M
Total Long-Term Liabilities
2.79B 2.81B 2.77B 2.78B
Total Liabilities
3.53B 3.33B 3.18B 3.3B
Total Debt
2.75B 2.55B 2.45B 2.36B
Common Stock
1.86M 1.81M 1.78M 1.74M
Retained Earnings
-4.5B -3.47B -3.27B -2.64B
Comprehensive Income
-944K 1.43M -5.24M -1.44M
Shareholders Equity
2.4B 3.15B 3.04B 3.39B
Total Investments
437.14M 172.27M 389.56M 715M